The drug is currently an investigational molecule and does not have regulatory approval
available as tablets, solution, and elixir)
Given the reduced levels of activated HGF and cMet in hepsin / mice, combined with the increased abundance of GJs, we hypothesize that these mice may be more vulnerable to oxidative stress, potentially exacerbating the severity of APAP-induced liver injury
Whilst Phase 2 data show a compelling efficacy signal, the drug remains unlicensed in the UK by the MHRA
however, the precise mechanisms and functional consequences remain to be elucidated
A: Its important to continue taking your medication as your healthcare provider prescribes, even if your blood sugar levels have improved